Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.

Detailed Quote for Merck & Company Inc. (new) (MRK)

Detailed Quote for Merck & Company Inc. (new) (MRK)

Sector News | Topic News
News for Merck & Company Inc. (new) (MRK)
Wed, May 22, 2019
8:49 AM OncoSec's TAVO shows encouraging action in mid-stage TNBC study - SeekingAlpha
8:00 AM Merck Foundation Announces Grant to American Cancer Society to Improve Access to Cancer Care in Resource-Limited Settings - Business Wire
Tue, May 21, 2019
2:30 PM Pfizer: Added Value For A Defensive Pharma Portfolio - SeekingAlpha
10:40 AM Merck KGaA FDA Approval Moves It Towards A Competitive Space - SeekingAlpha
7:00 AM Merck to acquire Peloton Therapeutics for up to $2.2B - SeekingAlpha
6:45 AM Merck to Acquire Peloton Therapeutics, Bolstering Oncology Pipeline - Business Wire
Mon, May 20, 2019
4:30 PM Merck Provides Update on Phase 3 KEYNOTE-119 Study of KEYTRUDA\u00AE (pembrolizumab) Monotherapy in Previously-Treated Patients with Metastatic Triple-Negative Breast Cancer - Business Wire
Sat, May 18, 2019
4:21 PM Cel-Sci's Phase 3 Multikine Trial Has 'Not Yet Hit The Primary Endpoint' - SeekingAlpha
Fri, May 17, 2019
9:50 AM Shares Of KalVista Are Nearing Buy Territory Again - SeekingAlpha
Thu, May 16, 2019
3:44 PM Moderna Aims To Revolutionize Modern Medicine With A New Class Of Drugs - SeekingAlpha
7:17 AM Iovance up 28% premarket on positive TIL data - SeekingAlpha
Wed, May 15, 2019
8:04 PM XOMA Corporation: Royalty Aggregation Strategy Likely To Pay Off - SeekingAlpha
5:00 PM New Research from Merck's Broad Oncology Clinical Development Program to be Presented at 2019 ASCO Annual Meeting - Business Wire
11:33 AM Galectin Therapeutics: Primed For Takeoff After The Rights Offering And New Clinical Evidence - SeekingAlpha
8:00 AM Tracking Ken Fisher's Fisher Asset Management Portfolio - Q1 2019 Update - SeekingAlpha
Tue, May 14, 2019
4:00 PM 5 Top Pharmaceutical ETFs - Investing News Network
Mon, May 13, 2019
5:51 PM IPO Update: Peloton Therapeutics Aims For $150 Million IPO - SeekingAlpha
9:47 AM Bullish Caution At Mid-Quarter - SeekingAlpha
7:43 AM FDA finalizes guidance on interchangeable biosimilars - SeekingAlpha
More News for MRK >>
Filings for Merck & Company Inc. (new) (MRK)
Thu, May 23, 2019
3:00 AM Specialized Disclosure Report - Form SD
More Filings for MRK >>